Earlier this month the World Intellectual Property Organization released its biennial report on the global state of innovation and intellectual property.

The Government of Canada has announced a consultation focused on potential amendments to the Copyright Act...

The Canadian Intellectual Property Office (CIPO) administered the 2020 Patent Agent Qualification Examination online last week via remote electronic delivery.

The World Intellectual Property Organization (WIPO) Digital Access Service (DAS) allows for simple and secure electronic exchange of priority patent applications between participating intellectual...

The Canadian Intellectual Property Office (CIPO) has launched a new online national entry request tool for Canadian national phase entries of international PCT patent applications.

The Canadian Intellectual Property Office (CIPO) has released a new practice notice clarifying its practice regarding requests for extensions of time under subsection 3(1) of the Patent Rules.

The Canadian Intellectual Property Office (CIPO) has released a new practice notice clarifying the effect of the Designated Days on maintenance fee due dates.

On 1 March 2023 the Copyright Board of Canada published and brought into effect the final version of their Rules of Practice and Procedure (the "Rules").

The Canadian Intellectual Property Office (CIPO) published a practice notice on May 3, 2021 confirming that the CIPO will now begin to accept requests for expedited examination of trademark...

In the recent decision of Munchkin, Inc. v. Angelcare Canada Inc., 2024 FCA 156, the Federal Court of Appeal upheld the Federal Court's decision finding Munchkin...

The Federal Court of Appeal has upheld the first ever website blocking order. In 2019 the Federal Court issued an order for Canadian internet service providers (ISPs) to block websites operating under the name "GoldTV"

On 13 July 2020, the US Supreme Court released its October schedule, which includes hearing oral arguments in the longstanding copyright dispute between Google and Oracle America on 7 October 2020.

A recent study published by the United States Patent and Trademark Office (the "USPTO") found that the number of artificial intelligence related patent applications had more than doubled in 2018 from 2002.

The Canadian Intellectual Property Office (CIPO) has released a new practice notice providing guidance on CIPO's approach...

The Canadian Intellectual Property Office has dramatically reduced trademark examination wait times to approximately 7.2 months for applications filed in April 2026, down from delays that previously stretched multiple years.

The Federal Court of Appeal examined whether McCain Foods' patent for treating vegetables using high electric fields was infringed by J.R. Simplot's pulsed electric field systems operating at significantly higher voltages. The case centered on interpreting the term "high electric field" and whether it encompassed the voltage ranges used by the defendant's technology.

A Federal Court decision highlights the critical importance of intellectual property clauses in consulting agreements, demonstrating how companies can face substantial statutory damages when they continue using copyrighted works after breaching payment terms with independent contractors. The case examines whether ongoing use of educational materials constitutes copyright infringement when no IP transfer was documented in the original contract.

Canadian artists should take note as an Artist's Resale Right may be on the horizon in Canada. In its 2025 Budget, the Canadian federal government announced its intention to create...

Canadian trademark owners facing a "use" challenge must provide clear, specific, and time-relevant evidence to show use of the trademark...

The Supreme Court of Canada has issued a landmark ruling on whether methods of medical treatment can be patented in Canada, addressing a long-standing prohibition that has shaped the country's intellectual property landscape. The decision examines the boundaries between patentable medical innovations and unpatentable professional medical judgment, with particular focus on dosing regimens and treatment protocols. This ruling provides critical guidance for pharmaceutical companies, patent practitioners, and h